Five minutes with…Börge Seeger, Neuwerk

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Five minutes with…Börge Seeger, Neuwerk

Börge Seeger - portrait (8).jpg

Börge Seeger reveals the similarities between IP strategy and F1, and opines on bookshops, espresso machines, and late-night emails

Welcome to the latest instalment of Managing IP’s ‘Five minutes with’ series, where we learn more about IP practitioners on a personal as well as a professional level. This time we have Börge Seeger, partner at Neuwerk in Germany.

Someone asks you at a party what you do for a living. What do you say?

I usually say something like: ‘I help life science companies do amazing things with their IP – getting drugs and diagnostics to market, building partnerships, making deals happen.’

If they’re still with me, I add: ‘It’s part law, part strategy, part translator between science and business.’

If they’ve already wandered off to the bar, I just say I’m a lawyer. Works either way.

Talk us through a typical working day.

Coffee. Inbox. Calls. Drafts. Repeat. No two days are the same, which I love. I might be negotiating a licensing agreement with a US biotech in the morning, reviewing a collaboration deal with a university hospital at noon, and advising a client on IP strategy for AI-powered diagnostics in the afternoon.

Plus, a few late-night WhatsApps with clients who just had an idea.

What are you working on at the moment?

A few pretty exciting things: A cross-border licensing and equity deal for a biotech client, a major out-licensing project involving an mRNA platform, and helping a pharma company restructure its global supply arrangements. And, on the side, getting bio.law (our online legal hub for the life sciences sector) ready for its next content wave.

Does one big piece of work usually take priority or are you juggling multiple things?

Always juggling – and mostly loving it. But when there’s a pivotal negotiation or a critical milestone, it tends to dominate everything else. The trick is to know when to focus hard and when to multitask like a maniac.

What is the most exciting aspect of your role, and what is the most stressful?

Exciting: Being right there when something new and bold gets off the ground – a first-in-class therapy, a breakthrough platform, a deal that opens new markets. Stressful: The just-one-more-turn-of-the-agreement emails at 11:47pm the night before signing.

Tell us the key characteristics that make a successful IP lawyer/practitioner.

Curiosity (you have to want to understand the tech). Clarity (translating science and strategy into something contractual). And resilience – IP law isn’t for the faint-hearted.

What is the most common misconception about IP?

That it’s just ‘legal protection’ or ‘something you register.’ It’s not. It’s often the entire value of the business. Getting IP strategy wrong is like putting bad fuel in a Formula 1 car.

What or who inspires you?

People who build things that matter. Young founders who bootstrap their science to clinical proof-of-concept. Nobel-prize-worthy researchers who stay curious. Clients who think big and get it done.

If you weren’t in IP, what would you be doing?

I’d probably run a bar somewhere sunny. Ideally, with a bookshop next door. Or maybe work in tech policy – I’m fascinated by the digital-health-AI-regulatory crossroads. Or both. Can you be a bartender/lawyer/philosopher?

Any advice you would give your younger self?

Take the call. Say yes to Stanford. Don’t worry too much – and always write that follow-up email.

What is your motto in life?

“Don’t overthink it – do the thing.” Also: “Smart, not fancy.” Applies to contracts, people, and espresso machines.

more from across site and SHARED ros bottom lb

More from across our site

Leaders at US law firms explain what attorneys can learn from AI cases involving Meta and Anthropic, and why the outcomes could guide litigation strategies
Attorneys reveal the trademark and copyright trends they’ve noticed within the first half of 2025
Senior leaders at TE Connectivity and Clarivate explain how they see the future of innovation
A new action filed by Nokia against Asus and a landmark ruling on counterfeits by South Africa’s Supreme Court were also among the top talking points
Counsel explain how they’re navigating patent prosecution matters and highlight key takeaways from Federal Circuit cases
A partner who joined Fenwick alongside two others explains what drew her to the firm and her hopes for growth in Boston
The England and Wales High Court has granted Kirkland & Ellis client Samsung interim declaratory relief in its ongoing FRAND dispute with ZTE
A UDRP decision that found in favour of a small business in a domain name dispute could encourage more businesses to take a stand in ‘David v Goliath’ cases
In Iconix v Dream Pairs, the Supreme Court said the Court of Appeal was wrong to interfere with an earlier ruling, prompting questions about the appeal court’s remit
Chris Moore at HGF reflects on the ‘spirit of collegiality’ that led to an important ruling in G1/24, a case concerning how European patent claims should be interpreted
Gift this article